JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, H. Q.
Right arrow Articles by Yin, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, H. Q.
Right arrow Articles by Yin, H. L.

J Biol Chem, Vol. 274, Issue 47, 33179-33182, November 19, 1999

MINIREVIEW
Gelsolin, a Multifunctional Actin Regulatory Protein*

Hui Qiao Sun, Masaya Yamamoto, Marisan Mejillano, and Helen L. Yinddager

From the Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9040

    INTRODUCTION
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

The actin cytoskeleton is an essential scaffold for integrating membrane and intracellular functions. It is very dynamic and is remodeled in response to a variety of signals. Growth factor stimulation promotes actin assembly at the plasma membrane to generate movement, whereas apoptotic signals cause cytoskeletal destruction to elicit characteristic membrane blebbing and morphological changes. Gelsolin is a Ca2+- and polyphosphoinositide 4,5-bisphosphate (PIP2)1-regulated actin filament severing and capping protein that is implicated in actin remodeling in growing and in apoptotic cells (reviewed in Refs. 1 and 2).

This review summarizes data supporting the role of gelsolin in cytoskeletal remodeling and phosphoinositide signaling and discusses the structural basis for the Ca2+ and PIP2 regulation of severing and capping by gelsolin.

    Overview about Severing, Capping, and Uncapping
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

Gelsolin is the most potent actin filament severing protein identified to date. Severing is the weakening of enough non-covalent bonds between actin molecules within a filament to break the filament in two. Gelsolin severs stoichiometrically and with close to 100% efficiency (3). Severing is initiated after gelsolin binds to the side of an actin filament. Gelsolin binds filaments rapidly but severs slowly (3); the delay may reflect the time required for structural rearrangement within gelsolin (see "Structural Basis for Ca2+ Regulation") and in the filament (4) prior to severing. Gelsolin changes actin conformation and kinks the actin filament (4), suggesting a mechanical basis for severing.

After severing, gelsolin remains attached to the barbed end of the filament as a cap. As a result, short actin filaments that cannot reanneal with each other or elongate at their barbed ends are generated. In this way, the actin network is disassembled. The importance of Ca2+-mediated actin severing has been clearly documented during platelet activation (5), and gelsolin is the only known Ca2+-dependent severing protein identified to date. Gelsolin severing can also have a constructive effect because it increases the number of filaments. Uncapping of gelsolin from these filaments generates many polymerization-competent ends from which actin can grow to rebuild the cytoskeleton to new specifications. Therefore, gelsolin can promote actin polymerization by severing followed by uncapping (mechanism B, as discussed in the Prologue (74) of this series).

    Gelsolin Functions in Vivo
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

The Gelsolin Null Mouse Establishes the Importance of Gelsolin for Multiple Cell Functions-- Cells from gelsolin null mice exhibit a variety of motility and actin defects. Gelsolin null fibroblasts have pronounced actin stress fibers (6), and this phenotype is consistent with an inability to sever and remodel actin filaments. They do not ruffle in response to growth factor (7), and they exhibit defective chemotaxis and wound healing. The rate of clotting is reduced (6), as would be consistent with the requirement of actin severing for platelet activation (5). Neurite retraction is defective (8), and neurons are more susceptible to glutamate-induced excito-toxicity (9). Neutrophil extravasation is compromised (6). These findings establish the importance of gelsolin in maintaining motility and actin dynamics.

Despite multiple cellular pathology, the null animals (in a mixed strain background) are without gross phenotypic defects. This may reflect the existence of potent compensatory mechanisms. However, the compensation is incomplete and varies with the genetic background of the knockout animals. Gelsolin null animals in a pure strain mouse background are non-viable at perinatal and early postnatal stages (2), indicating that gelsolin is necessary for survival.

Membrane ruffling is a functional readout for a coordinated series of membrane and cytoskeletal events, and it is activated by the small GTPase, Rac. Gelsolin null fibroblasts have increased Rac expression (7), and Rac·GTP dissociates gelsolin-actin complexes (equivalent to uncapping) in cell extracts but not purified gelsolin-actin complexes (10). These results suggest that gelsolin is a downstream effector of Rac, but there are additional steps between Rac and gelsolin activation/inactivation. A number of studies suggest that linkage through the type I phosphatidylinositol 5-kinases (PIP5KIs), the major enzymes that synthesize PIP2 (reviewed in Refs. 11 and 12), is an attractive possibility.

The Role of PIP2 in the Regulation of Cell Motility-- PIP5KIs coimmunoprecipitate with Rac (13) and also Rho (14), a small GTPase that promotes stress fiber formation. PIP5KIs may thus be incorporated into signaling complexes that are targeted to the plasma membrane through Rac·GTP or Rho·GTP. This increases the local concentration of PIP2 in membrane microdomains to selectively activate downstream cascades (reviewed in Refs. 12 and 15).

PIP2 has a pivotal role in the phosphoinositide cycle that drives signaling, cytoskeletal organization, and membrane trafficking (reviewed in Ref. 15). Numerous cytoskeletal proteins are affected by PIP2 in vitro. They include gelsolin family proteins (16), profilin (17), capping protein (18), ADF/cofilin (19), alpha -actinin (20), vinculin (21), ezrin/radixin/moesin (22), and WASp family proteins (23). The latter four proteins are activated by PIP2, whereas the first four are inactivated by PIP2. Ezrin/radixin/moesin, ADF/cofilin, and WASp are reviewed in this series (24-26). The challenge will be to identify cytoskeletal proteins that are physiologically regulated by PIP2 and determine how they are differentially regulated.

PIP2 involvement in cytoskeletal regulation is supported by experiments that manipulate PIP2 content in intact cells and in cell-free models. Microinjection of a monoclonal antibody to PIP2 prevents stress fiber and focal adhesion formation (21). PIP5KI overexpression induces the formation of short actin bundles (27) and increases the movement of dynamic actin spots containing a number of actin regulatory proteins (28). In contrast, overexpression of synaptojanin, the inositol polyphosphate 5-phosphatase that dephosphorylates PIP2, reduces actin stress fibers (29). Moreover, Hartwig et al. (30) were able to reconstitute the entire pathway between thrombin stimulation, Rac activation, PIP2 synthesis, and barbed end nucleated actin assembly in permeabilized platelets. However, in neutrophils and other systems, the relation is less clear. Although Rac·GTP dissociates gelsolin-actin complexes (10) and stimulates PIP2 synthesis, it does not promote actin assembly in lysates (31). Instead, Cdc42, which stimulates filopodia formation in cells, promotes de novo actin assembly in vitro, in a PIP2-dependent manner that is mediated through WASp and the Arp2/3 complex (32).

The range of responses and the contradictory effects of small GTPases and PIP2 on nucleated actin assembly in vivo and in vitro and in different types of cells may be reconciled by postulating that there are multiple pathways for actin assembly. Plasma membrane lysis may disrupt the critical coupling between Rac and actin polymerization much more than that between Cdc42 and actin.

Effects of Gelsolin Overexpression on Cell Motility and Signaling-- Gelsolin overexpression increases membrane ruffling and chemotaxis (33, 34), consistent with the role of gelsolin in dynamic actin remodeling. Surprisingly, CapG, a gelsolin relative that caps but does not sever actin, and the completely unrelated capping protein also increase cell motility when overexpressed (35, 36). A priori, pure capping proteins are expected to be less effective in promoting actin dynamics than severing/capping proteins, because they do not increase the number of actin filaments per se (compare mechanisms B (severing and uncapping) and C (uncapping only) in the Prologue to this minireview series (74)).

These results indicate that capping/uncapping may be sufficient to increase actin dynamics. More detailed study will be required to distinguish between the contributions of severing and capping.

Overexpression studies reveal that gelsolin may have other roles in addition to direct cytoskeletal regulation. Overexpressed gelsolin (34) and CapG (35) modulate phospholipase Cgamma and phospholipase Cbeta activity in a biphasic manner both in vivo and in vitro. These effects depend on PIP2 binding (34), suggesting that gelsolin enhances or competes with other PIP2-binding proteins for their common substrate. This potent effect may be achieved by altering the packing of PIP2 molecules within the membrane bilayer (37).

In conclusion, these results suggest that as PIP2 content and availability change during signaling, cross-talk between PIP2-regulated proteins provides a selective mechanism for positive as well as negative regulation of phosphoinositide signaling. This is particularly relevant as more PIP2-regulated proteins are identified. Gelsolin coimmunoprecipitates with several PIP2-interacting proteins, and it alters the activity of phosphatidylinositol 3-kinase and phospholipase D as well (reviewed in Refs. 1 and 2). Gelsolin is phosphorylated by c-Src in vitro, and phosphorylation is enhanced by PIP2 (38). The physiological significance of these associations and phosphorylation has not been determined.

Gelsolin and Apoptosis-- Gelsolin is a substrate for caspase-3 (39, 40), the effector caspase in both the death receptor and mitochondrial apoptotic pathways. Gelsolin cleaved by caspase-3 no longer requires Ca2+ to sever actin filaments (Fig. 1) (see also "Structural Basis for Ca2+ Regulation"), and it dismantles the membrane cytoskeleton to cause blebbing, a hallmark of apoptosis. Overexpression of the Ca2+-independent severing N-half induces apoptosis, whereas gelsolin null neutrophils have a delayed onset of apoptosis (39). These findings highlight the importance of inhibiting gelsolin severing to preserve the integrity of the cell and to selectively activate gelsolin under proliferative conditions.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Gelsolin structure-function domains. Residues are numbered as in human plasma gelsolin (43), and segmental boundaries are based on the structural definitions defined by the gelsolin crystal (44). Actin, PIP2, and Ca2+-binding segments are shown.

The pro-apoptotic role of gelsolin is supported by the finding that most cancer cells (which usually have reduced apoptosis) have significantly lower gelsolin expression (41) (reviewed in Ref. 2). Furthermore, gelsolin overexpression, especially of a mutant form that is more sensitive to PIP2, suppresses Ras transformation (42). Nevertheless, other data do not fit into this straightforward scheme. One group found that gelsolin overexpression protects against apoptosis (39). The relation between gelsolin, apoptosis, and tumorigenesis probably reflects a complex balance between the multiple effector functions of gelsolin.

    Gelsolin Structure-Function
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

The structural basis for gelsolin regulation by Ca2+ is now beginning to be understood. Gelsolin has two tandem homologous halves, each of which contains a 3-fold segmental repeat (segments S1-S3 and S4-S6, respectively) (43, 44) (Fig. 1). The N- and C-halves are connected by a long linker, which is cleaved by caspase-3 (39, 40) in vivo and in vitro, and by many other proteases in vitro. The isolated C-half binds a single actin molecule only when Ca2+ is above 10-6 M.2 The isolated N-half binds two actin molecules to sever and cap, even in the absence of Ca2+. Because severing by full-length gelsolin requires 10-6 M Ca2+, the C-half must act as a regulatory domain to inhibit severing by the N-half. In addition, the C-half potentiates severing by the N-half, possibly through cooperative binding to the filament (3).

There are two published high resolution structures of gelsolin, and a third is on its way. We will discuss results from the first two structures here and review results from the third structure later under "Structural Basis for Ca2+ Regulation." The S1-actin-Ca2+ structure (46) shows how a single gelsolin segment binds actin. Because of the similarities between segments (43, 44), it can be used as a template for modeling how the other segments bind actin. The full-length gelsolin crystal formed in the absence of Ca2+ (gelsolin/EGTA) shows that inactive gelsolin has a compact quarternary structure in the absence of Ca2+ (44). Its two halves are held together by a C-terminal S6 tail, which latches onto S2 (Figs. 1 and 2A) (the tail latch, see "Structural Basis for Ca2+ Regulation." Within each half, the first and third segments (S1 and S3, S4 and S6, respectively, for the N- and C-halves) are joined into a 10-strand beta -sheet that is sterically incompatible with actin binding (Fig. 2B). This explains why neither S1 nor S4 binds actin in the absence of Ca2+. It also predicts that Ca2+ must induce major conformational changes in each half and in the relation between the halves to accommodate actin binding.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 2.   Structural model of gelsolin in the absence of Ca2+. A, full-length gelsolin; B, gelsolin N- and C-halves. Figure was provided by R. Robinson. S1-S6, gelsolin segments 1-6; N and C, N- and C-terminal half, respectively.

A recent cryoelectron microscopic study of a gelsolin construct missing S1 attached to an actin filament (4) hints at the extent of the change that is required. The reconstructed image shows that gelsolin S2-S6 binds to actin molecules in neighboring filament strands (via S2 and S4). The distances between the S2 and S4 and the S1 and S2 actin-binding sites on the filament indicate that there must be large scale conformational changes before S1, S2, and S4 can simultaneously bind actin. The convoluted linker probably unwinds, and parts of the S1 or S2 core domain may have to unravel to extend the linker between S1 and S2 (as proposed in Refs. 44 and 47). A model for how this sequence of events may occur is shown in Fig. 3.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 3.   Schematic model for gelsolin binding, severing, and capping of an actin filament. This figure is based on data found in Refs. 4 and 47 and Footnote 3. Actin molecules within a filament are shown as blue circles. (+), barbed end; (-), minus end. Left, gelsolin in the process of Ca2+ activation. This requires tail unlatching, domain separation within each half, and separation of the halves. Middle, S2-S3 binds to the side of an actin filament via S2. S1 wedges between two actins in the longitudinal axis. This step requires a rearrangement of the S1-S2 interface to lengthen the S1-S2 linker. S4-S6 reaches across the filament to bind actin at the other strand. This step would require, at a minimum, extension of the convoluted linker between S3 and S4. Severing occurs when sufficient actin-actin bonds are broken. Right, the terminal actin in each strand is capped by S1 and S4. PIP2 induces gelsolin to dissociate from the ends in a process called uncapping.

Structural Basis for Ca2+ Regulation

The questions of how gelsolin is clamped in the inactive configuration under submicromolar Ca2+ conditions and how Ca2+ switches gelsolin on are clearly important because they pertain to proliferative and apoptotic signaling.

Multiple Ca2+-binding Sites-- Although gelsolin was first identified as a Ca2+-regulated protein that binds two Ca2+ with 10-6 M Kd (48), subsequent studies find that gelsolin interaction with Ca2+ is considerably more complex. Isolated gelsolin domains have at least three Ca2+-binding sites, with submicromolar and micromolar Kd values (49). On binding actin, intermolecular and intramolecular Ca2+-binding sites are created (46, 50),3 so gelsolin can potentially bind even more Ca2+ ions. Paradoxically, a recent study finds that gelsolin binds only two Ca2+ ions in the presence of actin, and they bind cooperatively (52). The challenge will be to determine which of the currently identified Ca2+-binding sites are physiologically relevant and how their occupancy alters gelsolin conformation.

At 37 °C, half-maximal severing is observed at 2 × 10-6 M Ca2+,2 which is well within the physiological range encountered during surface receptor stimulation. A small decrease in pH also reduces the Ca2+ requirement for severing significantly (53-55), suggesting that gelsolin can integrate these signals to generate fine-tuned responses in cells.

The C-half Talks to the N-half through the Tail Latch Mechanism-- Biochemical and physical studies indicate that Ca2+ opens up gelsolin by inducing a conformational change in the C-half to expose actin-binding sites on the N-half. The gelsolin/EGTA crystal structure shows that the C terminus of gelsolin has a tail extension that contains an unstructured strand capped with a short terminal helix (Fig. 1). The tail helix is in close contact with the actin binding helix of S2 (Fig. 2A) and may act as a latch to inhibit actin binding by the N-half in the absence of Ca2+. This is called the tail latch hypothesis.

The importance of the S6 tail in Ca2+ regulation is now supported by deletion studies. Deletion of the tail helix decreases the Ca2+ concentration for half-maximal activation of severing from 2 × 10-6 M to 10-7 M,2 whereas deletion of the entire tail abolishes the Ca2+ requirement for severing altogether (57).2 Furthermore, tail helix deletion abolishes the change in intrinsic tryptophan fluorescence observed at 10-6 M Ca2+ but not that at submicromolar Ca2+ (53, 56).2 Therefore, the tail latch is the major switch that releases the final constraint on the N-half to initiate the severing cascade.

Gelsolin is unique among the gelsolin family proteins (see "The Gelsolin Superfamily") in relegating Ca2+ regulation of its N-half to the C-half through its tail. It may have evolved the unique tail latch mechanism to achieve stringent regulation of severing and capping and to permit dispensing with Ca2+ regulation entirely during apoptosis simply by cleaving the severing half from the regulatory half.

Ca2+ Activation of the Gelsolin C-half-- S4-S6 has remained a black box for many years, even though it is the primary Ca2+-activated switch for gelsolin. The Ca2+ activation model can now be refined considerably because a crystal structure of the C-half complexed with actin and Ca2+ has just become available.3 As discussed above, in the absence of Ca2+, S4 and S6 are melded together into an extended beta -sheet (44) (Fig. 2B). In the presence of Ca2+, the beta -sheet is broken; S4 and S6 are completely separated along their interface. S6 swings away from S4 and forms new contacts with S5. Actin inserts into the space vacated by S6 and creates an intermolecular Ca2+-binding site coordinated by S4 and actin. These results confirm that that there are large scale domain rearrangements during Ca2+ activation.

Structural Basis for PIP2 Regulation

Although there is ample evidence for reversible gelsolin-actin association in cells (reviewed in Ref. 1), gelsolin uncapping after severing cannot be achieved simply by reducing Ca2+. This is because a Ca2+ molecule is trapped between gelsolin S1 and actin, and it is inaccessible to EGTA (46). Phosphoinositides, particularly PIP2 (16, 58), are the only known agents that inhibit gelsolin severing and dissociate gelsolin from actin in vitro (59).

Gelsolin binds PIP2 with micromolar affinity (55). Binding is enhanced by Ca2+ and by low pH (55). Gelsolin prefers PIP2 to phosphatidylinositol-3,4,5-P3 (58, 60, 61) and does not bind inositol trisphosphate (17). Therefore, gelsolin binding is stereoselective and enhanced by the diacylglycerol chain. This requirement is unlike the situation with many pleckstrin homology proteins, which bind phosphoinositides and the equivalent inositol phosphates with similar affinity (62).

Gelsolin can simultaneously bind between one and three PIP2 molecules within lipid vesicles, and binding is highly dependent on the physical characteristics of the bilayer (63). Therefore, gelsolin regulation by PIP2 does not depend simply on the absolute PIP2 mass but is rather dictated by a complex relation between lipid bilayer composition and geometry. This, together with the ability of gelsolin to change its affinity for PIP2 in response to Ca2+ and pH (55) and to induce changes in PIP2 packing within the membrane (37), hints at the large number of signals that are sensed and integrated by gelsolin to carry out its functions. In addition, we are just beginning to appreciate the active role gelsolin may have in modulating phosphoinositide signaling (see "Effects of Gelsolin Overexpression on Cell Motility and Signaling").

PIP2 inhibits the gelsolin N-half, and the N-half PIP2 binding sequences are mapped to a common flat, solvent-exposed surface in the linker between S1-S2 and the beginning of S2 in the gelsolin/EGTA crystal (Fig. 1). These sites have an acidic amino acid consensus that does not resemble the pleckstrin homology domain (64, 65). PIP2 induces a conformational change (55, 66) that may interfere with the local rearrangements required to permit S2 and S1 to bind two actin molecules simultaneously (Fig. 3). Structural information about gelsolin complexed with PIP2 will be required to determine whether this is how PIP2 inhibits gelsolin and if PIP2 binds to other gelsolin domains as well.

    The Gelsolin Superfamily
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

Many members of the gelsolin family that have three or six gelsolin repeats have been identified (reviewed in Refs. 1 and 2). They have distinct as well as overlapping patterns of tissue expression, which is consistent with specialized function (67). Except for gelsolin, Ca2+ regulation and actin binding are not segregated into the two halves of the molecule. For example, villin, a six-domain protein, has a Ca2+-dependent N-half (68), and CapG, a three-domain protein, has built-in Ca2+ regulation in its actin-binding segment (69).

Novel members with long N-terminal extensions have also been discovered. For example, flightless I has an N-terminal extension of 16 tandem leucine-rich repeats (70), which can potentially mediate heterologous protein-protein interactions. Its binding partners include a family of novel proteins with coiled coil repeats (71, 72) and possibly Ras (73). Through these interactions, flightless I may link the actin cytoskeleton to intracellular and membrane structures to integrate signaling responses.

    Conclusions and Perspectives
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

This review has focused on the intracellular functions of gelsolin and emphasizes progress made to obtain a mechanistic model of how gelsolin regulates the actin cytoskeleton in response to Ca2+ and phosphoinositide signaling. With a clear understanding of how actin regulatory proteins work individually, we are now poised to delineate how they cooperate to orchestrate actin dynamics within living cells. Some progress has already been made. One study shows that gelsolin and capping protein coordinately cap barbed ends during platelet activation (73). Another study finds that filaments capped by gelsolin and Arp2/3 at the barbed and pointed ends, respectively, can still undergo rapid turnover in the presence of ADF/cofilin, and new uncapped barbed ends are generated (51). Therefore, gelsolin severing and capping can theoretically promote de novo nucleation by Arp2/3 by increasing the number of pointed filament ends and increasing the actin monomer pool (45). These findings extend the scope of the involvement of gelsolin in regulating actin dynamics.

    FOOTNOTES

* This minireview will be reprinted in the 1999 Minireview Compendium, which will be available in December, 1999. This is the second article of four in the "Proteins That Regulate Dynamic Actin Remodeling in Response to Membrane Signaling Minireview Series." This work was supported by National Institutes of Health Grant GM51112 and Robert A. Welch Foundation Grant I-1200.

2 K.-M. Lin, M. Mejillano, and H. L. Yin, submitted for publication.

3 R. C. Robinson, M. Mejillano, V. Le, L. D. Burtnick, H. L. Yin, and S. Choe, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: PIP2, polyphosphoinositide 4,5-bisphosphate; PIP5KI, phosphatidylinositol 5-kinase.

    REFERENCES
TOP
INTRODUCTION
Overview about Severing,...
Gelsolin Functions in Vivo
Gelsolin Structure-Function
The Gelsolin Superfamily
Conclusions and Perspectives
REFERENCES

1. Liu, Y. T., Rozelle, A. L., and Yin, H. L. (1998) in G Proteins, Cytoskeleton and Cancer (Maruta, H. , and Kohama, K., eds) , pp. 19-35, R. G. Landes Company, Austin, TX
2. Kwiatkowski, D. J. (1999) Curr. Opin. Cell Biol. 11, 103-108[CrossRef][Medline] [Order article via Infotrieve]
3. Selden, L. A., Kinosian, H. J., Newman, J., Lincoln, B., Hurwitz, C., Gershman, L. C., and Estes, J. E. (1998) Biophys. J. 75, 3101-3109[Abstract/Free Full Text]
4. McGough, A., Chiu, W., and Way, M. (1998) Biophys. J. 74, 764-772[Abstract/Free Full Text]
5. Hartwig, J. H. (1992) J. Cell Biol. 118, 1421-1442[Abstract/Free Full Text]
6. Witke, W., Sharpe, A. H., Hartwig, J. H., Azuma, T., Stossel, T. P., and Kwiatkowski, D. J. (1995) Cell 81, 41-51[CrossRef][Medline] [Order article via Infotrieve]
7. Azuma, T., Witke, W., Stossel, T. P., Hartwig, J. H., and Kwiatkowski, D. J. (1998) EMBO J. 17, 1362-1370[CrossRef][Medline] [Order article via Infotrieve]
8. Lu, M., Witke, W., Kwiatkowski, D. J., and Kosik, K. S. (1997) J. Cell Biol. 138, 1279-1287[Abstract/Free Full Text]
9. Endres, M., Fink, K., Zhu, J., Stagliano, N. E., Bondala, V., Geddes, J. W., Azuma, T., Mattson, M. P., Kwiatkowski, D. J., and Moscowitz, M. A. (1999) J. Clin. Invest. 10, 161-178
10. Arcaro, A. (1998) J. Biol. Chem. 273, 805-813[Abstract/Free Full Text]
11. Fruman, D. A., Meyers, R. E., and Cantley, L. C. (1998) Annu. Rev. Biochem. 67, 481-507[CrossRef][Medline] [Order article via Infotrieve]
12. Anderson, R. A., Boronenkov, I. V., Doughman, S. D., Kunz, J., and Loijens, J. C. (1999) J. Biol. Chem. 274, 9907-9910[Free Full Text]
13. Tolias, K. F., Cantley, L. C., and Carpenter, C. L. (1995) J. Biol. Chem. 270, 17656-17659[Abstract/Free Full Text]
14. Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A. (1994) Cell 79, 507-513[CrossRef][Medline] [Order article via Infotrieve]
15. Toker, A. (1998) Curr. Opin. Cell Biol. 10, 254-261[CrossRef][Medline] [Order article via Infotrieve]
16. Janmey, P. A., and Stossel, T. P. (1987) Nature 325, 362-364[CrossRef][Medline] [Order article via Infotrieve]
17. Lassing, I., and Lindberg, U. (1985) Nature 314, 472-474[CrossRef][Medline] [Order article via Infotrieve]
18. Schafer, D. A., Jennings, P. B., and Cooper, J. A. (1996) J. Cell Biol. 135, 169-179[Abstract/Free Full Text]
19. Yonezawa, N., Nishida, E., Iida, K., Yahara, I., and Sakai, H. (1990) J. Biol. Chem. 265, 8382-8386[Abstract/Free Full Text]
20. Fukami, K., Furuhashi, K., Inagaki, M., Endo, T., Hatano, S., and Takenawa, T. (1992) Nature 359, 150-152[CrossRef][Medline] [Order article via Infotrieve]
21. Gilmore, A. P., and Burridge, K. (1996) Nature 381, 531-535[CrossRef][Medline] [Order article via Infotrieve]
22. Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., Takai, Y., and Tsukita, S. (1996) J. Cell Biol. 135, 37-51[Abstract/Free Full Text]
23. Miki, H., Miura, K., and Takenawa, T. (1996) EMBO J. 15, 5326-5335[Medline] [Order article via Infotrieve]
24. Higgs, H. N., and Pollard, T. D. (1999) J. Biol. Chem. 274, 32531-32534[Free Full Text]
25. Tsukita, S., and Yonemura, S. (1999) J. Biol. Chem. 274, 34507-34510[Free Full Text]
26. Carlier, M.-F., Ressad, F., and Pantaloni, D. (1999) J. Biol. Chem. 274, 33827-33830[Free Full Text]
27. Shibasaki, Y., Ishihara, H., Kizuki, N., Asano, T., Oka, Y., and Yazaki, Y. (1997) J. Biol. Chem. 272, 7578-7581[Abstract/Free Full Text]
28. Schafer, D. A., Welch, M. D., Machesky, L. M., Bridgman, P. C., Meyer, S. M., and Cooper, J. A. (1998) J. Cell Biol. 143, 1919-1930[Abstract/Free Full Text]
29. Sakisaka, T., Itoh, T., Miura, K., and Takenawa, T. (1997) Mol. Cell. Biol. 17, 3841-3849[Abstract]
30. Hartwig, J. H., Bokoch, G. M., Carpenter, C. L., Janmey, P. A., Taylor, L. A., Toker, A., and Stossel, T. P. (1995) Cell 82, 643-653[CrossRef][Medline] [Order article via Infotrieve]
31. Zigmond, S. H., Joyce, M., Borleis, J., Bokoch, G. M., and Devreotes, P. N. (1997) J. Cell Biol. 138, 363-374[Abstract/Free Full Text]
32. Rohatgi, R., Ma, L., Miki, H., Lopez, M., Kirchhausen, T., Takenawa, T., and Kirschner, M. W. (1999) Cell 97, 221-231[CrossRef][Medline] [Order article via Infotrieve]
33. Cunningham, C. C., Stossel, T. P., and Kwiatkowski, D. J. (1991) Science 251, 1233-1236[Abstract/Free Full Text]
34. Sun, H.-Q., Lin, K.-M., and Yin, H. L. (1997) J. Cell Biol. 138, 811-820[Abstract/Free Full Text]
35. Sun, H.-Q., Kwiatkowska, K., Wooten, D. C., and Yin, H. L. (1995) J. Cell Biol. 129, 147-156[Abstract/Free Full Text]
36. Hug, C., Jay, P. Y., Reddy, I., McNally, J. G., Bridgman, P. C., Elson, E. L., and Cooper, J. A. (1995) Cell 81, 591-600[CrossRef][Medline] [Order article via Infotrieve]
37. Flanagan, L. A., Cunningham, C. C., Chen, J., Prestwich, G. D., Kosik, K. S., and Janmey, P. A. (1997) Biophys. J. 73, 1440-1447[Abstract/Free Full Text]
38. De Corte, V., Gettesmans, J., and Vandekerckhove, J. (1997) FEBS Lett. 401, 191-196[CrossRef][Medline] [Order article via Infotrieve]
39. Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J., and Williams, L. T. (1997) Science 278, 294-298[Abstract/Free Full Text]
40. Kamada, S., Kusano, H., Fujita, H., Ohtsu, M., Koya, R. C., Kuzumaki, N., and Tsujimoto, Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8532-8537[Abstract/Free Full Text]
41. Dong, Y., Asch, H. L., Medina, D., Ip, M., Guzman, R., and Asch, B. B. (1999) Int. J. Cancer 81, 930-938[CrossRef][Medline] [Order article via Infotrieve]
42. Fujita, H., Laham, L. E., Janmey, P. A., Kwiatkowski, D. J., Stossel, T. P., Banno, Y., Nozawa, Y., Mllauer, L., Ishizaki, A., and Kuzumaki, N. (1995) Eur. J. Biochem. 229, 615-620[Medline] [Order article via Infotrieve]
43. Kwiatkowski, D. P., Stossel, T. P., Orkin, S. H., Mole, J. E., Colten, H. R., and Yin, H. L. (1986) Nature 323, 455-458[CrossRef][Medline] [Order article via Infotrieve]
44. Burtnick, L. D., Koepf, E. K., Grimes, J., Jones, E. Y., Stuart, D. I., McLaughlin, P. J., and Robinson, R. C. (1997) Cell 90, 661-670[CrossRef][Medline] [Order article via Infotrieve]
45. Ressard, F., Didry, D., Egile, C., Pantaloni, D., and Carlier, M. F. (1999) J. Biol. Chem. 274, 20970-20977[Abstract/Free Full Text]
46. McLaughlin, P. J., Gooch, J. T., Mannherz, H.-G., and Weeds, A. G. A. (1993) Nature 364, 685-692[CrossRef][Medline] [Order article via Infotrieve]
47. McGough, A. (1998) Curr. Opin. Struct. Biol. 8, 166-176[CrossRef][Medline] [Order article via Infotrieve]
48. Yin, H. L., Zaner, K. S., and Stossel, T. P. (1980) J. Biol. Chem. 255, 9494-9500[Abstract/Free Full Text]
49. Pope, B., Maciver, S., and Weeds, A. (1995) Biochemistry 34, 1583-1588[CrossRef][Medline] [Order article via Infotrieve]
50. Weeds, A. G., Gooch, J., McLaughlin, P., Pope, B., Bengtsdotter, M., and Karlsson, R. (1995) FEBS Lett. 360, 227-230[CrossRef][Medline] [Order article via Infotrieve]
51. Barkalow, K., Witke, W., Kwiatkowski, D. J., and Hartwig, J. H. (1996) J. Cell Biol. 134, 389-399[Abstract/Free Full Text]
52. Gremm, D., and Wegner, A. (1999) Eur. J. Biochem. 262, 330-334[Medline] [Order article via Infotrieve]
53. Kinosian, H. J., Newman, J., Lincoln, B., Selden, L. A., Gershman, L. C., and Estes, J. E. (1998) Biophys. J. 75, 3092-3100[Abstract/Free Full Text]
54. Lamb, J. A., Allen, P. G., Tuan, B. Y., and Janmey, P. A. (1993) J. Biol. Chem. 268, 8999-9004[Abstract/Free Full Text]
55. Lin, K.-M., Wenegieme, E. F., Lu, P.-J., Chen, C.-S., and Yin, H. L. (1997) J. Biol. Chem. 272, 20443-20450[Abstract/Free Full Text]
56. Pope, B. J., Gooch, J. T., and Weeds, A. G. (1997) Biochemistry 36, 15848-15855[CrossRef][Medline] [Order article via Infotrieve]
57. Kwiatkowski, D. P., Janmey, P. A., and Yin, H. L. (1989) J. Cell Biol. 108, 1717-1726[Abstract/Free Full Text]
58. Lu, P. J., Wang, D. S., Lin, K. M., Yin, H. L., and Chen, C. S. (1999) Am. Chem. Soc. Symp. Ser. 718, 38-54
59. Janmey, P. A., Iida, K., Yin, H. L., and Stossel, T. P. (1987) J. Biol. Chem. 262, 12228-12236[Abstract/Free Full Text]
60. Lu, P. J., Hsu, A.-L., Wang, D.-S., Yan, H., Yin, H. L., and Chen, C. S. (1998) Biochemistry 37, 5738-5745[CrossRef][Medline] [Order article via Infotrieve]
61. Hartwig, J. H., Kung, S., Kovacsovics, T., Janmey, P. A., Cantley, L. C., Stossel, T. P., and Toker, A. (1996) J. Biol. Chem. 271, 32986-32993[Abstract/Free Full Text]
62. Rameh, L. E., Arvidsson, A.-K., Carraway, K. L., III, Couvillon, A. D., Rathbun, G., Crompton, A., VanRenterghem, B., Czech, M. P., Ravichandran, K. S., Burakoff, S. J., Wang, D.-S., Chen, C.-S., and Cantley, L. C. (1997) J. Biol. Chem. 272, 22059-22066[Abstract/Free Full Text]
63. Tuominen, E. K. J., Holopainen, J. M., Chen, J., Prestwich, G. D., Bachiller, P. R., Kinnunen, P. K. J., and Janmey, P. A. (1999) Eur. J. Biochem. 262, 1-9[Medline] [Order article via Infotrieve]
64. Janmey, P. A., Lamb, J., Allen, P. G., and Matsudaira, P. T. (1992) J. Biol. Chem. 267, 11818-11823[Abstract/Free Full Text]
65. Yu, F.-X., Sun, H.-Q., Janmey, P. A., and Yin, H. L. (1992) J. Biol. Chem. 267, 14616-14621[Abstract/Free Full Text]
66. Xian, W., Vegners, R., Janmey, P. A., and Braunlin, W. H. (1995) Biophys. J. 69, 2695-2702[Abstract/Free Full Text]
67. Arai, M., and Kwiatkowski, D. J. (1999) Dev. Dyn. 215, 297-307[CrossRef][Medline] [Order article via Infotrieve]
68. Matsudaira, P., Jakes, R., and Walker, J. E. (1985) Nature 315, 248-250[CrossRef][Medline] [Order article via Infotrieve]
69. Yu, F.-X., Johnston, P. A., Sudhof, T. C., and Yin, H. L. (1990) Science 250, 1413-1415[Abstract/Free Full Text]
70. Campbell, H. D., Schimansky, T., Claudianos, C., Ozsarac, N., Kasprzak, A. B., Cotsell, J. N., Young, I. G., de Couet, H. G., and Miklos, G. L. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11386-11390[Abstract/Free Full Text]
71. Liu, Y. T., and Yin, H. L. (1998) J. Biol. Chem. 273, 7920-7927[Abstract/Free Full Text]
72. Fong, K. S., and de Couet, H. G. (1999) Genomics 58, 146-157[CrossRef][Medline] [Order article via Infotrieve]
73. Goshima, M., Kariya, K., Yamawaki-Kataoka, Y., Okada, T., Shibatohge, M., Shima, F., Fujimoto, E., and Kataoka, T. (1999) Biochem. Biophys. Res. Commun. 257, 111-116[CrossRef][Medline] [Order article via Infotrieve]
74. Yin, H. L., and Stull, J. T. (1999) J. Biol. Chem. 274, 32529-32530[Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
C.-L. Huang
Complex roles of PIP2 in the regulation of ion channels and transporters
Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1761 - F1765.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Jia, M. Omelchenko, D. Garland, V. Vasiliou, J. Kanungo, M. Spencer, Y. Wolf, E. Koonin, and J. Piatigorsky
Duplicated gelsolin family genes in zebrafish: a novel scinderin-like gene (scinla) encodes the major corneal crystallin
FASEB J, October 1, 2007; 21(12): 3318 - 3328.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
H. Deng, D. Xia, B. Fang, and H. Zhang
The Flightless I Homolog, fli-1, Regulates Anterior/Posterior Polarity, Asymmetric Cell Division and Ovulation During Caenorhabditis elegans Development
Genetics, October 1, 2007; 177(2): 847 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Q. P. Noguchi, N. Kanzaki, H. Ueno, K. Hirose, and T. Q. P. Uyeda
A Novel System for Expressing Toxic Actin Mutants in Dictyostelium and Purification and Characterization of a Dominant Lethal Yeast Actin Mutant
J. Biol. Chem., September 21, 2007; 282(38): 27721 - 27727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Ashish, M. S. Paine, P. B. Perryman, L. Yang, H. L. Yin, and J. K. Krueger
Global Structure Changes Associated with Ca2+ Activation of Full-length Human Plasma Gelsolin
J. Biol. Chem., August 31, 2007; 282(35): 25884 - 25892.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
Y. Xiang, X. Huang, T. Wang, Y. Zhang, Q. Liu, P. J. Hussey, and H. Ren
ACTIN BINDING PROTEIN29 from Lilium Pollen Plays an Important Role in Dynamic Actin Remodeling
PLANT CELL, June 1, 2007; 19(6): 1930 - 1946.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Yermen, A. Tomas, and P. A. Halban
Pro-Survival Role of Gelsolin in Mouse {beta}-Cells
Diabetes, January 1, 2007; 56(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. M. Miano, X. Long, and K. Fujiwara
Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C70 - C81.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
X. Song, X. Chen, H. Yamaguchi, G. Mouneimne, J. S. Condeelis, and R. J. Eddy
Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells
J. Cell Sci., July 15, 2006; 119(14): 2871 - 2881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Sakurai and T. Utsumi
Posttranslational N-Myristoylation Is Required for the Anti-apoptotic Activity of Human tGelsolin, the C-terminal Caspase Cleavage Product of Human Gelsolin
J. Biol. Chem., May 19, 2006; 281(20): 14288 - 14295.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Tomas, B. Yermen, L. Min, J. E. Pessin, and P. A. Halban
Regulation of pancreatic {beta}-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway
J. Cell Sci., May 15, 2006; 119(10): 2156 - 2167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Uruno, K. Remmert, and J. A. Hammer III
CARMIL Is a Potent Capping Protein Antagonist: IDENTIFICATION OF A CONSERVED CARMIL DOMAIN THAT INHIBITS THE ACTIVITY OF CAPPING PROTEIN AND UNCAPS CAPPED ACTIN FILAMENTS
J. Biol. Chem., April 14, 2006; 281(15): 10635 - 10650.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. S. Ada-Nguema, H. Xenias, M. P. Sheetz, and P. J. Keely
The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLC{epsilon}
J. Cell Sci., April 1, 2006; 119(7): 1307 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. D. Apostolova, T. Christova, and D. M. Templeton
Involvement of Gelsolin in Cadmium-Induced Disruption of the Mesangial Cell Cytoskeleton
Toxicol. Sci., February 1, 2006; 89(2): 465 - 474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. A. Osborn, A. Rabodzey, C. F. Dewey Jr., and J. H. Hartwig
Endothelial actin cytoskeleton remodeling during mechanostimulation with fluid shear stress
Am J Physiol Cell Physiol, February 1, 2006; 290(2): C444 - C452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Candiano, M. Bruschi, N. Pedemonte, E. Caci, S. Liberatori, L. Bini, C. Pellegrini, M. Vigano, B. J. O'Connor, T. H. Lee, et al.
Gelsolin Secretion in Interleukin-4-treated Bronchial Epithelia and in Asthmatic Airways